Delivery Order SPE2DB24D2205-SPE2DB25FEFMW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $27,668.94 to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Priorix vials with a completion deadline of August 4, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The contract is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order valued at $2,427.10 to AmerisourceBergen Drug Corp for Priorix vials on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed price delivery order was issued without a set-aside designation and represents a competitive award under the company's broader pharmaceutical supply agreement with DLA. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a $18,169.56 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Priorix vials with a completion date of July 24, 2025. This competitively awarded, non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded a delivery order valued at $8,354.34 to AmerisourceBergen Drug Corp for the supply of Priorix vials on August 18, 2025, with a completion date of August 19, 2025. This firm fixed-price delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation. Work will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Priorix vials, valued at $35,329.70. This firm fixed-price delivery order, which is expected to be completed by July 23, 2025, was issued without a set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,588.60, is for the delivery of Priorix vials, a vaccine product. This is a firm fixed-price delivery order contract with a completion date of November 6, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PRIORIX vials valued at $10,892.18 under a Firm Fixed Price contract type. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive procurement. PRIORIX is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, and this delivery order falls under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $1,755.30 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for Priorix vials, a measles, mumps, and rubella vaccine product. This firm fixed-price contract, with a completion date of July 29, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order will be fulfilled at AmerisourceBergen's facility in...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $49,166.40 contract is for the delivery of Priorix vials, a vaccine product, with a period of performance through July 2024. The contract is not designated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency Troop Support Medical awarded a $3,805.55 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561837158 units of Priorix vaccine vials. The place of performance is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. The period of performance is August 16-17, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFMWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $24,753 to AmerisourceBergen Drug Corp for Priorix vials, with an ultimate completion date of July 30, 2025. This non-set-aside contract was competitively awarded on a firm fixed price basis and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. Priorix is a vaccine product, consistent with AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical procurement. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The company's extensive portfolio of federal awards demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.8k | 7/29/25 |